Home World News FDA Grants Traditional Approval to Selpercatinib for Locally Advanced or Metastatic RET... World News FDA Grants Traditional Approval to Selpercatinib for Locally Advanced or Metastatic RET Fusion-Positive Solid Tumours By Ogkologos - September 2, 2026 114 0 Facebook Twitter Google+ Pinterest WhatsApp Evidence for efficacy is based on the results from the LIBRETTO-001 and LIBRETTO-121 studies Source RELATED ARTICLESMORE FROM AUTHOR Can ctDNA guide treatment intensification in EGFR mutated non-small cell lung cancer? How to select adjuvant endocrine therapy for postmenopausal women with HR-positive early breast cancer? EMA Recommends Extension of Therapeutic Indications for Abiraterone Acetate MOST POPULAR ER-Low Positive Breast Cancer Shows Similar Clinical Behaviour and Response to... August 6, 2021 Does Eating Processed Meat Increase Your Risk for Cancer? September 19, 2023 Pine Trees or COVID? September 2, 2020 Study Identifies Potential Drug Target to Prevent Some Liver Cancers February 4, 2022 Load more HOT NEWS Cancer-impacted mother becomes Times Square billboard to help child come across... CCDI Activities Enhance NCI’s Childhood and AYA Cancer Research Coming Full Circle on Cancer and Extrachromosomal DNA Tucatinib Added to Trastuzumab and Capecitabine Continues to Demonstrate a Significant...